FeesSafety
Pluang+

JBS Q3 misses EPS but beats revenue; 'Buy' rating upheld on valuation and recovery prospects

Company Fundamentals
13 Nov 2026, 17:58 WIB
Seeking Alpha
View Source
Neutral
JBS Q3 misses EPS but beats revenue; 'Buy' rating upheld on valuation and recovery prospects

JBS reported Q3 results with earnings per share below expectations but revenue surpassing forecasts. The company faced margin pressure due to higher cattle costs, exhausted Chinese export quotas, and weak U.S. pork demand. Despite these challenges, JBS remains attractively valued, trading at a significant discount compared to peers, supported by diversified operations. The analyst maintains a 'Buy' rating, noting potential risks like leverage and export limits but optimistic about recovery in U.S. beef and Chinese demand.

JBS's Q3 results provide context for readers interested in consumer staples. For readers following this sector, here is Pluang's market snapshot as of Nov 13, 2026 22:51 WIB: out of 63 priced Consumer Staples-sector US stocks, 53 rose and 9 fell. Notable movers include Vital Farms Inc (VITL) at USD 9.21 with a 2.62% increase, e l f Beauty Inc (ELF) at USD 116.49 up 2.61%, and General Mills, Inc. (GIS) at USD 34.29 rising 2.30% with 100% buy order activity on Pluang.

More News

Solo integrates human verification into JellyJelly app as AI agents bypass CAPTCHA tests.

Solo integrates human verification into JellyJelly app as AI agents bypass CAPTCHA tests.

Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...

Others
Bullish
20 minutes ago
U.S. AI-enabled ophthalmic diagnostic devices market to hit $267M by 2033 with 20.5% CAGR.

U.S. AI-enabled ophthalmic diagnostic devices market to hit $267M by 2033 with 20.5% CAGR.

The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous...

Market News
Bullish
20 minutes ago
Medical display monitors market to grow to $4B by 2033 driven by digital imaging and healthcare modernization

Medical display monitors market to grow to $4B by 2033 driven by digital imaging and healthcare modernization

The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...

Market News
Bullish
21 minutes ago
Nokia executive Pallavi Mahajan buys 89 shares at €7.63 each on Nov 12, 2026

Nokia executive Pallavi Mahajan buys 89 shares at €7.63 each on Nov 12, 2026

On November 12, 2026, Nokia executive Pallavi Mahajan acquired 89 shares of Nokia Corporation at a price of €7.63 per share. This insider purchase is officially reported under EU Market Abuse Regulation Article 19. Such transactions by company execut...

Market News
Neutral
1 hour ago
Nokia executive Victoria Hanrahan buys 6 shares at €7.63 each on Nov 12, 2026

Nokia executive Victoria Hanrahan buys 6 shares at €7.63 each on Nov 12, 2026

Victoria Hanrahan, a senior executive at Nokia Corporation, purchased 6 shares of Nokia stock at a price of €7.63 per share on November 12, 2026. This transaction was reported under EU Market Abuse Regulation Article 19, indicating transparency in in...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App